{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:26:28Z","timestamp":1790015188400,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","award":["2023-YBSF-243"],"award-info":[{"award-number":["2023-YBSF-243"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","award":["2024ZC-KJXX-085"],"award-info":[{"award-number":["2024ZC-KJXX-085"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72304221"],"award-info":[{"award-number":["72304221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72274153"],"award-info":[{"award-number":["72274153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejim.2025.07.022","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:22:13Z","timestamp":1753442533000},"page":"106426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials"],"prefix":"10.1016","volume":"142","author":[{"given":"Di","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoni","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-1495","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0001","first-page":"187","article-title":"Annual review of venous thromboembolism in 2022","volume":"46","author":"Xi","year":"2023","journal-title":"Chin J Tubercul Respirat Disease"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00134-022-06850-7","article-title":"Thromboprophylaxis in critical care","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-024-00756-w","article-title":"Hemorrhages and risk factors in patients undergoing thromboprophylaxis in a respiratory critical care unit: a secondary data analysis of a cohort study","volume":"12","author":"Lyu","year":"2024","journal-title":"J Intensive Care"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5603\/AA.2017.0008","article-title":"Venous thromboembolism \u2014 Recommendations on the prevention, diagnostic approach and management. The 2017 Polish consensus statement","volume":"23","author":"Tomkowski","year":"2017","journal-title":"Acta Angiologica"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0392-9590.23.05177-5","article-title":"Prevention and management of venous thromboembolism. International consensus statement. Guidelines according to scientific evidence","volume":"43","author":"Nicolaides","year":"2024","journal-title":"Int Angiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2020-000643","article-title":"Venous thromboembolism prophylaxis in the trauma intensive care unit: an American association for the surgery of trauma critical care committee clinical consensus document","volume":"6","author":"Rappold","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0007","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chest.2021.08.050","article-title":"VTE prophylaxis in critically ill adults: a systematic review and network meta-analysis","volume":"161","author":"Fernando","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2025.07.022_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070022","article-title":"Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis","volume":"378","author":"Eck","year":"2022","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ejim.2025.07.022_bib0009","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jclinepi.2010.06.005","article-title":"Appraising a tool for guideline appraisal (the AGREE II instrument)","volume":"63","author":"Dans","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: the RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ejim.2025.07.022_bib0011","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.ejim.2025.07.022_bib0012","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"Cmaj"},{"key":"10.1016\/j.ejim.2025.07.022_bib0013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ejim.2025.07.022_bib0014","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejim.2025.07.022_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jclinepi.2020.08.019","article-title":"Controversy and debate: questionable utility of the relative risk in clinical research: paper 1: a call for change to practice","volume":"142","author":"Doi","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"47","key":"10.1016\/j.ejim.2025.07.022_bib0016","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehu424","article-title":"Systematic reviews and meta-analyses of randomized trials: principles and pitfalls","volume":"35","author":"Da Costa","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.07.022_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074495","article-title":"A guide and pragmatic considerations for applying GRADE to network meta-analysis","volume":"381","author":"Izcovich","year":"2023","journal-title":"BMJ"},{"issue":"2 Suppl","key":"10.1016\/j.ejim.2025.07.022_bib0018","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12028-015-0221-y","article-title":"Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the neurocritical care society","volume":"24","author":"Nyquist","year":"2016","journal-title":"Neurocrit Care"},{"issue":"22","key":"10.1016\/j.ejim.2025.07.022_bib0020","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.ejim.2025.07.022_bib0021","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ejim.2025.07.022_bib0022","first-page":"793","article-title":"Guidelines for the prevention of deep vein thrombosis in ICU patients","volume":"29","author":"Ma","year":"2009","journal-title":"Chin J Practical Surg"},{"issue":"6","key":"10.1016\/j.ejim.2025.07.022_bib0023","first-page":"561","article-title":"Expert consensus on the prevention of venous thromboembolism for elderly patients with critical illness in China (2023)","volume":"35","author":"Yan","year":"2023","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ejim.2025.07.022_bib0024","unstructured":"Scottish intercollegiate guidelines network. Prevention and management of venous thromboembolism. 2014. Sign. https:\/\/www.sign.ac.uk. Accessed October 2014."},{"key":"10.1016\/j.ejim.2025.07.022_bib0025","series-title":"Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism","year":"2019"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2025.07.022_bib0026","first-page":"S51","article-title":"Indian society of critical care medicine consensus statement for prevention of venous thromboembolism in the critical care unit","volume":"26","author":"Jagiasi","year":"2022","journal-title":"Indian J Crit Care Med"},{"issue":"11","key":"10.1016\/j.ejim.2025.07.022_bib0027","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15537\/smj.2016.11.15268","article-title":"The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients","volume":"37","author":"Al-Hameed","year":"2016","journal-title":"Saudi Med J"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0028","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3346\/jkms.2014.29.2.164","article-title":"Prevention of venous thromboembolism, 2nd edition: korean society of thrombosis and hemostasis evidence-based clinical practice guidelines","volume":"29","author":"Bang","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.ejim.2025.07.022_bib0029","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1378\/chest.13-2993","volume":"146","author":"Kristiansen","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0392-9590.16.03765-2","article-title":"Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism","volume":"36","author":"Liew","year":"2017","journal-title":"International angiology"},{"issue":"8","key":"10.1016\/j.ejim.2025.07.022_bib0031","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/EJA.0000000000002011","article-title":"European guidelines on peri-operative venous thromboembolism prophylaxis: first update","volume":"41","author":"Bounes","year":"2024","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0032","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00068-024-02443-9","article-title":"Comparison of the safety and efficacy for different regimens of pharmaco-prophylaxis among severely burned patients: a randomized controlled trial","volume":"50","author":"Al Sulaiman","year":"2024","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"7","key":"10.1016\/j.ejim.2025.07.022_bib0033","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijccm.IJCCM_23_17","article-title":"Bemiparin versus enoxaparin in the prevention of venous thromboembolism among intensive care unit patients","volume":"21","author":"Abbas","year":"2017","journal-title":"Indian J Crit Care Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.07.022_bib0034","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/TA.0000000000000750","article-title":"Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: a randomized noninferiority trial","volume":"79","author":"Olson","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"14","key":"10.1016\/j.ejim.2025.07.022_bib0035","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"Cook","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejim.2025.07.022_bib0036","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/bjs.4309","article-title":"Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma","volume":"90","author":"Ginzburg","year":"2003","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejim.2025.07.022_bib0037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199609053351003","article-title":"A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma","volume":"335","author":"Geerts","year":"1996","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.07.022_bib0038","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00268-004-7295-6","article-title":"Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin","volume":"28","author":"Kurtoglu","year":"2004","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0039","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH08-07-0468","article-title":"Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis","volume":"101","author":"Shorr","year":"2009","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/153857449903300219","article-title":"Prospective trial of low-molecular-weight heparin versus unfractionated heparin in moderately injured patients","volume":"33","author":"Cohn","year":"1999","journal-title":"Vasc Surg"},{"issue":"1","key":"10.1016\/j.ejim.2025.07.022_bib0041","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MBC.0b013e3283333505","article-title":"Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery","volume":"21","author":"De","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4 Pt 1","key":"10.1016\/j.ejim.2025.07.022_bib0042","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.161.4.9807025","article-title":"Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The association of non-university affiliated intensive care specialist physicians of France","volume":"161","author":"Fraisse","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.07.022_bib0043","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00134-013-2814-2","article-title":"Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial","volume":"39","author":"Vignon","year":"2013","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0044","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40262-022-01202-6","article-title":"Low and highly variable exposure to prophylactic LMWH nadroparin in critically ill patients: back to the drawing board for prophylactic dosing?","volume":"62","author":"Diepstraten","year":"2023","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","article-title":"Pharmacokinetic alterations associated with critical illness","volume":"62","author":"Morales Castro","year":"2023","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0046","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/cc8924","article-title":"effective dosage for intensive care patients: double-blinded, randomised clinical trial","volume":"14","author":"Robinson","year":"2010","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ejim.2025.07.022_bib0047","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/cc12684","article-title":"A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial","volume":"17","author":"Robinson","year":"2013","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ejim.2025.07.022_bib0048","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3346\/jkms.2013.28.3.466","article-title":"Antifactor xa levels in critically ill Korean patients receiving enoxaparin for thromboprophylaxis: a prospective observational study","volume":"28","author":"Lim","year":"2013","journal-title":"J Korean Med Sci"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:15:53Z","timestamp":1764659753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052500305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S095362052500305X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.07.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106426"}}